查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1790022

医疗数据收益市场规模、份额和趋势分析报告：按方法、组织规模、最终用途、地区和细分市场预测，2025 年至 2033 年

Data Monetization In Healthcare Market Size, Share & Trends Analysis Report By Method (Data As A Service, Insight As A Service), By Organization Size (Large Enterprises, SMEs), By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

医疗数据收益市场概览

2024 年，全球医疗保健数据收益市场规模估计为 5.716 亿美元，预计到 2033 年将达到 33.938 亿美元，2025 年至 2033 年的复合年增长率为 22.3%。这一增长是由电子健康记录(EHR) 的日益普及以及公共和私人对高级分析解决方案的投资增加所推动的。

随着人们日益意识到数据收益的优势，以及医疗公司对稳健数据管理策略的兴趣日益浓厚，医疗保健行业的数据货币化正经历显着增长。此外，区块链、机器学习 (ML)、人工智慧 (AI)、云端运算和巨量资料分析等新兴技术的采用也进一步推动了这一趋势。此外，数据收益软体和服务正助力製药、医疗保健和医疗科技公司取得切实可行的洞察，加速业务成长。此外，这些工具能够进行风险预测和异常检测，从而提高业务效率，并支援医疗保健领域数据收益的扩展。

在高阶分析平台与智慧自动化整合的推动下，医疗保健产业的数据收益正在快速转型，使企业能够更精准、更自主地提取、管理和收益数据。塑造这项变革的关键趋势是向基于代理的人工智慧和自主资料生态系统的转变，这些生态系统使医疗保健提供者、付款人和生命科学公司能够从海量资料集中释放潜在价值，同时确保合规性、安全性和情境智慧。这些平台与现有数据基础设施无缝集成，以实现即时洞察生成、异常检测、预测建模和收益优化。

例如，2025年5月，Brillio推出了ADAM，这是一个基于代理的开创性人工智慧平台，旨在推动整个企业的智慧资料自主。该系统实现了端到端资料生命週期的自动化，从资料收集和情境化到洞察提取和收益，从而加速了高级医疗资料的收益，无需持续的人工监督。 ADAM利用生成式人工智慧、认知代理和自我调整编配，使医疗保健相关人员能够将分段资料转化为可操作的收益资产。这一结果反映了市场的转变，即人工智慧驱动的数据平台不再仅仅支援医疗保健分析，而是正在成为业务成长、业务效率和竞争差异化的核心引擎。

目录

第一章调查方法与范围

第二章执行摘要

第三章医疗保健资料收益的变数、趋势和范围

  • 市场介绍/电网展望
  • 产业价值链分析
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 行业机会
  • 医疗分析工具中的数据收益
    • 波特分析
    • PESTEL分析

第四章：医疗保健数据收益市场：依方法进行的估算与趋势分析

  • 细分仪表板
  • 医疗保健数据收益：方法论差异分析（百万美元），2024 年对比 2033 年
  • DaaS（Data-as-a-Service）
  • IaaS（Insight-as-a-Service）
  • 具有分析功能的平台即服务 (PaaS)
  • 嵌入式分析

第五章：医疗保健数据收益市场：按组织规模的估计和趋势分析

  • 细分仪表板
  • 医疗保健数据收益：2024 年和 2033 年组织规模变化分析（百万美元）
  • 大公司
  • 小型企业

第六章：医疗保健数据收益市场——按最终用途进行的估算和趋势分析

  • 细分仪表板
  • 医疗保健数据收益：最终用途差异分析（百万美元），2024 年和 2033 年
  • 製药和生物技术公司
  • 医疗保健参与企业
  • 医疗技术公司
  • 其他的

第七章：医疗保健数据收益市场：区域、估计与趋势分析

  • 各地区医疗保健数据收益份额（2024 年和 2033 年，百万美元）
  • 北美洲
    • 按方法，2021-2033 年
    • 依组织规模，2021-2033 年
    • 依最终用途，2021-2033 年
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 依方法分类，2021-2033 年
    • 依组织规模，2021-2033 年
    • 依最终用途，2021-2033 年
    • 英国
    • 德国
    • 法国
  • 亚太地区
    • 依方法分类，2021-2033 年
    • 依组织规模，2021-2033 年
    • 依最终用途，2021-2033 年
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 依方法分类，2021-2033 年
    • 依组织规模，2021-2033 年
    • 依最终用途，2021-2033 年
    • 巴西
  • 中东和非洲
    • 依方法分类，2021-2033 年
    • 依组织规模，2021-2033 年
    • 依最终用途，2021-2033 年
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第八章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 2024年公司市场占有率分析
  • 公司热图分析
  • 战略地图
    • 扩张
    • 合併与收购
    • 伙伴关係和合作
    • 新产品发布
    • 研究与开发
  • 公司简介
    • Optum, Inc.
    • Oracle Corporation
    • SAS Institute Inc.
    • IBM Corporation
    • Microsoft Corporation
    • Google LLC
    • Snowflake Inc.
    • IQVIA Inc.
    • Flatiron Health, Inc.
    • Palantir Technologies Inc.
    • Truveta, Inc.
    • Arcadia Solutions LLC
    • Clarify Health Solutions, Inc.
    • Health Catalyst, Inc.
Product Code: GVR-4-68040-125-3

Data Monetization In Healthcare Market Summary

The global data monetization in healthcare market size was estimated at USD 571.6 million in 2024 and is projected to reach USD 3,393.8 million by 2033, growing at a CAGR of 22.3% from 2025 to 2033. The growth is attributed to the increasing adoption of electronic health records (EHRs) and rising public & private investments in advanced analytics solutions.

The data monetization in healthcare industry is experiencing significant growth, driven by increasing awareness of its benefits and a growing focus among healthcare enterprises on robust data management strategies. In addition, the adoption of emerging technologies such as Blockchain, Machine Learning (ML), Artificial Intelligence (AI), cloud computing, and big data analytics is further propelling this trend. Moreover, data monetization software and services enable pharmaceutical, healthcare, and medical technology companies to extract actionable insights, thereby accelerating business growth. Furthermore, these tools enhance operational efficiency by enabling risk prediction and anomaly detection, supporting the expansion of data monetization in healthcare landscape.

The data monetization in healthcare industry is undergoing rapid transformation, fueled by the convergence of advanced analytics platforms and intelligent automation that enable organizations to extract, manage, and monetize data with greater precision and autonomy. A key trend shaping this evolution is the shift toward agentic AI and autonomous data ecosystems that empower healthcare providers, payers, and life sciences firms to unlock latent value from vast datasets, while ensuring compliance, security, and contextual intelligence. These platforms integrate seamlessly with existing data infrastructures, enabling real-time insights generation, anomaly detection, predictive modeling, and revenue optimization.

For instance, in May 2025, Brillio launched ADAM, a pioneering agentic AI platform designed to drive intelligent data autonomy across enterprises. This system facilitates advanced healthcare data monetization by empowering users to automate the end-to-end data lifecycle from acquisition and contextualization to insight extraction and monetization without constant human oversight. By harnessing generative AI, cognitive agents, and adaptive orchestration, ADAM enables healthcare stakeholders to turn fragmented data silos into actionable, revenue-generating assets. Consequently, this reflects a market shift where AI-powered data platforms are not just supporting healthcare analytics but transforming them into core engines of business growth, operational efficiency, and competitive differentiation.

Global Data Monetization In Healthcare Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global data monetization in healthcare market report based on method, organization size, end use, and region:

  • Method Outlook (Revenue, USD Million, 2021 - 2033)
  • Data As A Service
  • Insight As A Service
  • Analytics-enabled Platform As A Service
  • Embedded Analytics
  • Organization Size Outlook (Revenue, USD Million, 2021 - 2033)
  • Large Enterprises
  • SMEs
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Healthcare Players
  • Medical Technology Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Latin America
    • Brazil
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Methodology segmentation & scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Organization Size

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Data Monetization in Healthcare Variables, Trends & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Industry Value Chain Analysis
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
    • 3.3.3. Industry Opportunities
  • 3.4. Data Monetization in Healthcare Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Data Monetization in Healthcare Market: Method Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Data Monetization in Healthcare: Method Movement Analysis, USD Million, 2024 & 2033
  • 4.3. Data as a service
    • 4.3.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Insight as a service
    • 4.4.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Analytics-enabled platform as a service
    • 4.5.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Embedded analytics
    • 4.6.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Data Monetization in Healthcare Market: Organization Size Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Data Monetization in Healthcare: Organization Size Movement Analysis, USD Million, 2024 & 2033
  • 5.3. Large Enterprises
    • 5.3.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. SMEs
    • 5.4.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Data Monetization in Healthcare Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Data Monetization in Healthcare: End Use Movement Analysis, USD Million, 2024 & 2033
  • 6.3. Pharmaceutical and Biotechnology Companies
    • 6.3.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Healthcare Players
    • 6.4.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Medical Technology Companies
    • 6.5.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Data Monetization in Healthcare Market: Regional Estimates & Trend Analysis

  • 7.1. Data Monetization in Healthcare Share, By Region, 2024 & 2033, USD Million
  • 7.2. North America
    • 7.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
    • 7.2.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
    • 7.2.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
    • 7.2.5. U.S.
      • 7.2.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 7.2.5.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
      • 7.2.5.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
      • 7.2.5.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
    • 7.2.6. Canada
      • 7.2.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 7.2.6.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
      • 7.2.6.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
      • 7.2.6.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
    • 7.2.7. Mexico
      • 7.2.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 7.2.7.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
      • 7.2.7.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
      • 7.2.7.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
  • 7.3. Europe
    • 7.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
    • 7.3.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
    • 7.3.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
    • 7.3.5. UK
      • 7.3.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 7.3.5.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
      • 7.3.5.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
      • 7.3.5.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
    • 7.3.6. Germany
      • 7.3.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 7.3.6.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
      • 7.3.6.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
      • 7.3.6.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
    • 7.3.7. France
      • 7.3.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 7.3.7.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
      • 7.3.7.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
      • 7.3.7.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
    • 7.4.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
    • 7.4.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
    • 7.4.5. China
      • 7.4.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 7.4.5.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
      • 7.4.5.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
      • 7.4.5.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
    • 7.4.6. India
      • 7.4.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 7.4.6.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
      • 7.4.6.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
      • 7.4.6.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
    • 7.4.7. Japan
      • 7.4.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 7.4.7.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
      • 7.4.7.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
      • 7.4.7.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
    • 7.4.8. Australia
      • 7.4.8.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 7.4.8.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
      • 7.4.8.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
      • 7.4.8.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
    • 7.4.9. South Korea
      • 7.4.9.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 7.4.9.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
      • 7.4.9.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
      • 7.4.9.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
  • 7.5. Latin America
    • 7.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
    • 7.5.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
    • 7.5.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
    • 7.5.5. Brazil
      • 7.5.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 7.5.5.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
      • 7.5.5.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
      • 7.5.5.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
  • 7.6. Middle East & Africa
    • 7.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
    • 7.6.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
    • 7.6.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
    • 7.6.5. Saudi Arabia
      • 7.6.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 7.6.5.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
      • 7.6.5.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
      • 7.6.5.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
    • 7.6.6. UAE
      • 7.6.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 7.6.6.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
      • 7.6.6.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
      • 7.6.6.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
    • 7.6.7. South Africa
      • 7.6.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 7.6.7.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
      • 7.6.7.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
      • 7.6.7.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Market Share Analysis, 2024
  • 8.4. Company Heat Map Analysis
  • 8.5. Strategy Mapping
    • 8.5.1. Expansion
    • 8.5.2. Mergers & Acquisition
    • 8.5.3. Partnerships & Collaborations
    • 8.5.4. New Product Launches
    • 8.5.5. Research And Development
  • 8.6. Company Profiles
    • 8.6.1. Optum, Inc.
      • 8.6.1.1. Participant's Overview
      • 8.6.1.2. Financial Performance
      • 8.6.1.3. Product Benchmarking
      • 8.6.1.4. Recent Developments
    • 8.6.2. Oracle Corporation
      • 8.6.2.1. Participant's Overview
      • 8.6.2.2. Financial Performance
      • 8.6.2.3. Product Benchmarking
      • 8.6.2.4. Recent Developments
    • 8.6.3. SAS Institute Inc.
      • 8.6.3.1. Participant's Overview
      • 8.6.3.2. Financial Performance
      • 8.6.3.3. Product Benchmarking
      • 8.6.3.4. Recent Developments
    • 8.6.4. IBM Corporation
      • 8.6.4.1. Participant's Overview
      • 8.6.4.2. Financial Performance
      • 8.6.4.3. Product Benchmarking
      • 8.6.4.4. Recent Developments
    • 8.6.5. Microsoft Corporation
      • 8.6.5.1. Participant's Overview
      • 8.6.5.2. Financial Performance
      • 8.6.5.3. Product Benchmarking
      • 8.6.5.4. Recent Developments
    • 8.6.6. Google LLC
      • 8.6.6.1. Participant's Overview
      • 8.6.6.2. Financial Performance
      • 8.6.6.3. Product Benchmarking
      • 8.6.6.4. Recent Developments
    • 8.6.7. Snowflake Inc.
      • 8.6.7.1. Participant's Overview
      • 8.6.7.2. Financial Performance
      • 8.6.7.3. Product Benchmarking
      • 8.6.7.4. Recent Developments
    • 8.6.8. IQVIA Inc.
      • 8.6.8.1. Participant's Overview
      • 8.6.8.2. Financial Performance
      • 8.6.8.3. Product Benchmarking
      • 8.6.8.4. Recent Developments
    • 8.6.9. Flatiron Health, Inc.
      • 8.6.9.1. Participant's Overview
      • 8.6.9.2. Financial Performance
      • 8.6.9.3. Product Benchmarking
      • 8.6.9.4. Recent Developments
    • 8.6.10. Palantir Technologies Inc.
      • 8.6.10.1. Participant's Overview
      • 8.6.10.2. Financial Performance
      • 8.6.10.3. Product Benchmarking
      • 8.6.10.4. Recent Developments
    • 8.6.11. Truveta, Inc.
      • 8.6.11.1. Participant's Overview
      • 8.6.11.2. Financial Performance
      • 8.6.11.3. Product Benchmarking
      • 8.6.11.4. Recent Developments
    • 8.6.12. Arcadia Solutions LLC
      • 8.6.12.1. Participant's Overview
      • 8.6.12.2. Financial Performance
      • 8.6.12.3. Product Benchmarking
      • 8.6.12.4. Recent Developments
    • 8.6.13. Clarify Health Solutions, Inc.
      • 8.6.13.1. Participant's Overview
      • 8.6.13.2. Financial Performance
      • 8.6.13.3. Product Benchmarking
      • 8.6.13.4. Recent Developments
    • 8.6.14. Health Catalyst, Inc.
      • 8.6.14.1. Participant's Overview
      • 8.6.14.2. Financial Performance
      • 8.6.14.3. Product Benchmarking
      • 8.6.14.4. Recent Developments

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 Global Data Monetization in Healthcare market, 2021 - 2033 (USD Million)
  • Table 3 Global Data Monetization in Healthcare market, by Region, 2021 - 2033 (USD Million)
  • Table 4 Global Data Monetization in Healthcare market, by Method, 2021 - 2033 (USD Million)
  • Table 5 Global Data Monetization in Healthcare market, by Organization Size, 2021 - 2033 (USD Million)
  • Table 6 Global Data Monetization in Healthcare market, by End Use, 2021 - 2033 (USD Million)
  • Table 7 Global Data as a service market by region, 2021 - 2033 (USD Million)
  • Table 8 Global Insight as a service market by region, 2021 - 2033 (USD Million)
  • Table 9 Global Analytics-enabled platform as a service market by region, 2021 - 2033 (USD Million)
  • Table 10 Global Embedded analytics market by region, 2021 - 2033 (USD Million)
  • Table 11 Global Large Enterprises market by region, 2021 - 2033 (USD Million)
  • Table 12 Global SMEs market by region, 2021 - 2033 (USD Million)
  • Table 13 Global Pharmaceutical and Biotechnology Companies market by region, 2021 - 2033 (USD Million)
  • Table 14 Global Healthcare Players market by region, 2021 - 2033 (USD Million)
  • Table 15 Global Medical Technology Companies market by region, 2021 - 2033 (USD Million)
  • Table 16 Global Others market by region, 2021 - 2033 (USD Million)
  • Table 17 North America Data Monetization in Healthcare market, by Method, 2021 - 2033 (USD Million)
  • Table 18 North America Data Monetization in Healthcare market, by Organization Size, 2021 - 2033 (USD Million)
  • Table 19 North America Data Monetization in Healthcare market, by End Use, 2021 - 2033 (USD Million)
  • Table 20 U.S. Data Monetization in Healthcare market, by Method, 2021 - 2033 (USD Million)
  • Table 21 U.S. Data Monetization in Healthcare market, by Organization Size, 2021 - 2033 (USD Million)
  • Table 22 U.S. Data Monetization in Healthcare market, by End Use, 2021 - 2033 (USD Million)
  • Table 23 Canada Data Monetization in Healthcare market, by Method, 2021 - 2033 (USD Million)
  • Table 24 Canada Data Monetization in Healthcare market, by Organization Size, 2021 - 2033 (USD Million)
  • Table 25 Canada Data Monetization in Healthcare market, by End Use, 2021 - 2033 (USD Million)
  • Table 26 Mexico Data Monetization in Healthcare market, by Method, 2021 - 2033 (USD Million)
  • Table 27 Mexico Data Monetization in Healthcare market, by Organization Size, 2021 - 2033 (USD Million)
  • Table 28 Mexico Data Monetization in Healthcare market, by End Use, 2021 - 2033 (USD Million)
  • Table 29 Europe Data Monetization in Healthcare market, by Method, 2021 - 2033 (USD Million)
  • Table 30 Europe Data Monetization in Healthcare market, by Organization Size, 2021 - 2033 (USD Million)
  • Table 31 Europe Data Monetization in Healthcare market, by End Use, 2021 - 2033 (USD Million)
  • Table 32 UK Data Monetization in Healthcare market, by Method, 2021 - 2033 (USD Million)
  • Table 33 UK Data Monetization in Healthcare market, by Organization Size, 2021 - 2033 (USD Million)
  • Table 34 UK Data Monetization in Healthcare market, by End Use, 2021 - 2033 (USD Million)
  • Table 35 Germany Data Monetization in Healthcare market, by Method, 2021 - 2033 (USD Million)
  • Table 36 Germany Data Monetization in Healthcare market, by Organization Size, 2021 - 2033 (USD Million)
  • Table 37 Germany Data Monetization in Healthcare market, by End Use, 2021 - 2033 (USD Million)
  • Table 38 France Data Monetization in Healthcare market, by Method, 2021 - 2033 (USD Million)
  • Table 39 France Data Monetization in Healthcare market, by Organization Size, 2021 - 2033 (USD Million)
  • Table 40 France Data Monetization in Healthcare market, by End Use, 2021 - 2033 (USD Million)
  • Table 41 Asia Pacific Data Monetization in Healthcare market, by Method, 2021 - 2033 (USD Million)
  • Table 42 Asia Pacific Data Monetization in Healthcare market, by Organization Size, 2021 - 2033 (USD Million)
  • Table 43 Asia Pacific Data Monetization in Healthcare market, by End Use, 2021 - 2033 (USD Million)
  • Table 44 China Data Monetization in Healthcare market, by Method, 2021 - 2033 (USD Million)
  • Table 45 China Data Monetization in Healthcare market, by Organization Size, 2021 - 2033 (USD Million)
  • Table 46 China Data Monetization in Healthcare market, by End Use, 2021 - 2033 (USD Million)
  • Table 47 India Data Monetization in Healthcare market, by Method, 2021 - 2033 (USD Million)
  • Table 48 India Data Monetization in Healthcare market, by Organization Size, 2021 - 2033 (USD Million)
  • Table 49 India Data Monetization in Healthcare market, by End Use, 2021 - 2033 (USD Million)
  • Table 50 Japan Data Monetization in Healthcare market, by Method, 2021 - 2033 (USD Million)
  • Table 51 Japan Data Monetization in Healthcare market, by Organization Size, 2021 - 2033 (USD Million)
  • Table 52 Japan Data Monetization in Healthcare market, by End Use, 2021 - 2033 (USD Million)
  • Table 53 Australia Data Monetization in Healthcare market, by Method, 2021 - 2033 (USD Million)
  • Table 54 Australia Data Monetization in Healthcare market, by Organization Size, 2021 - 2033 (USD Million)
  • Table 55 Australia Data Monetization in Healthcare market, by End Use, 2021 - 2033 (USD Million)
  • Table 56 South Korea Data Monetization in Healthcare market, by Method, 2021 - 2033 (USD Million)
  • Table 57 South Korea Data Monetization in Healthcare market, by Organization Size, 2021 - 2033 (USD Million)
  • Table 58 South Korea Data Monetization in Healthcare market, by End Use, 2021 - 2033 (USD Million)
  • Table 59 Latin America Data Monetization in Healthcare market, by Method, 2021 - 2033 (USD Million)
  • Table 60 Latin America Data Monetization in Healthcare market, by Organization Size, 2021 - 2033 (USD Million)
  • Table 61 Latin America Data Monetization in Healthcare market, by End Use, 2021 - 2033 (USD Million)
  • Table 62 Brazil Data Monetization in Healthcare market, by Method, 2021 - 2033 (USD Million)
  • Table 63 Brazil Data Monetization in Healthcare market, by Organization Size, 2021 - 2033 (USD Million)
  • Table 64 Brazil Data Monetization in Healthcare market, by End Use, 2021 - 2033 (USD Million)
  • Table 65 Middle East & Africa Data Monetization in Healthcare market, by Method, 2021 - 2033 (USD Million)
  • Table 66 Middle East & Africa Data Monetization in Healthcare market, by Organization Size, 2021 - 2033 (USD Million)
  • Table 67 Middle East & Africa Data Monetization in Healthcare market, by End Use, 2021 - 2033 (USD Million)
  • Table 68 UAE Data Monetization in Healthcare market, by Method, 2021 - 2033 (USD Million)
  • Table 69 UAE Data Monetization in Healthcare market, by Organization Size, 2021 - 2033 (USD Million)
  • Table 70 UAE Data Monetization in Healthcare market, by End Use, 2021 - 2033 (USD Million)
  • Table 71 Saudi Arabia Data Monetization in Healthcare market, by Method, 2021 - 2033 (USD Million)
  • Table 72 Saudi Arabia Data Monetization in Healthcare market, by Organization Size, 2021 - 2033 (USD Million)
  • Table 73 Saudi Arabia Data Monetization in Healthcare market, by End Use, 2021 - 2033 (USD Million)
  • Table 74 South Africa Data Monetization in Healthcare market, by Method, 2021 - 2033 (USD Million)
  • Table 75 South Africa Data Monetization in Healthcare market, by Organization Size, 2021 - 2033 (USD Million)
  • Table 76 South Africa Data Monetization in Healthcare market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Data Monetization in Healthcare Market Segmentation
  • Fig. 2 Market landscape
  • Fig. 3 Information Procurement
  • Fig. 4 Data Analysis Models
  • Fig. 5 Market Formulation and Validation
  • Fig. 6 Data Validating & Publishing
  • Fig. 7 Market Snapshot
  • Fig. 8 Segment Snapshot
  • Fig. 9 Competitive Landscape Snapshot
  • Fig. 10 Data Monetization in Healthcare: Industry Value Chain Analysis
  • Fig. 11 Data Monetization in Healthcare: Market Dynamics
  • Fig. 12 Data Monetization in Healthcare: PORTER's Analysis
  • Fig. 13 Data Monetization in Healthcare: PESTEL Analysis
  • Fig. 14 Data Monetization in Healthcare Share by Method, 2024 & 2033 (USD Million)
  • Fig. 15 Data Monetization in Healthcare, by Method: Market Share, 2024 & 2033
  • Fig. 16 Data as a service Market Estimates and Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 17 Insight as a service Market Estimates and Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 18 Analytics-enabled platform as a service Market Estimates and Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 19 Embedded analytics Market Estimates and Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 20 Data Monetization in Healthcare Share by Organization Size, 2024 & 2033 (USD Million)
  • Fig. 21 Data Monetization in Healthcare, by Organization Size: Market Share, 2024 & 2033
  • Fig. 22 Large Enterprises Market Estimates and Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 23 SMEs Market Estimates and Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 24 Data Monetization in Healthcare Share by End Use, 2024 & 2033 (USD Million)
  • Fig. 25 Data Monetization in Healthcare, by End Use: Market Share, 2024 & 2033
  • Fig. 26 Pharmaceutical and Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 27 Healthcare Players Market Estimates and Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 28 Medical Technology Companies Market Estimates and Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 29 Others Market Estimates and Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 30 Regional Market place: Key Takeaways
  • Fig. 31 North America Data Monetization in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 U.S. Data Monetization in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Canada Data Monetization in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Mexico Data Monetization in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Europe Data Monetization in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 UK Data Monetization in Healthcare Market Estimates and Forecasts, 2021 - 2033,) (USD Million)
  • Fig. 37 Germany Data Monetization in Healthcare Market Estimates and Forecasts (2021 - 2033,) (USD Million)
  • Fig. 38 France Data Monetization in Healthcare Market Estimates and Forecasts (2021 - 2033,) (USD Million)
  • Fig. 39 Asia Pacific Data Monetization in Healthcare Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 40 China Data Monetization in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 India Data Monetization in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Japan Data Monetization in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Australia Data Monetization in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 South Korea Data Monetization in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Latin America Data Monetization in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Brazil Data Monetization in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 MEA Data Monetization in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Saudi Arabia Data Monetization in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 UAE Data Monetization in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 South Africa Data Monetization in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key Company Categorization
  • Fig. 52 Company Market Positioning
  • Fig. 53 Key Company Market Share Analysis, 2024
  • Fig. 54 Strategic Framework